Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0129 | 0.2059 | 0.2059 |
Loa Loa (eye worm) | brahma associated protein | 0.0264 | 1 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0264 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0264 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0094 | 0 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0264 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0264 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0094 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.2059 | 0.2059 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0094 | 0 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0264 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Brugia malayi | Peptidase family M28 containing protein | 0.0129 | 0.2059 | 0.2059 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0264 | 1 | 1 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0129 | 0.2059 | 0.2059 |
Leishmania major | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0264 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0264 | 1 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0094 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0264 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0264 | 1 | 1 |
Onchocerca volvulus | 0.0264 | 1 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0264 | 1 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0264 | 1 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | glutaminyl cyclase (M28 family) | 0.0129 | 0.2059 | 0.2059 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0264 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0094 | 0 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0264 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0264 | 1 | 1 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0129 | 0.2059 | 0.2059 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0094 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0094 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0264 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0264 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0264 | 1 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0094 | 0 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0264 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0264 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.